Glutathione S-transferase gene polymorphisms in Turkish patients with diabetes mellitus

Cell Biochemistry and Function

Volumn 25, Issue 5, 2007, Pages 509-513

  Yalin, Serap ^a   Hatungil, Rezan ^b   Tamer, Lulufer ^b   Ates, Nurcan Aras ^b   Dogruer, Nil ^a   Yildirim, Hatice ^b   Karakas, Sevim ^b   Atik, Ugur ^b  

^a MERSIN UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Diabetes; Genetic polymorphism; Glutathione S transferase; GSTP1; Oxidative stress

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE MARKER; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TURKEY (REPUBLIC);

ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; TURKEY;

EID: 34548750898     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1339     Document Type: Article

References (23)

1. Seidergard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione S-transferase activity on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988; 85: 7293-7297.
2. Awasthi YC, Sharma R, Singhal SS. Human glutathione S-transferases: minireview. Int J Biochem 1994; 26: 295-308.
3. Garte S. Metabolic susceptibility genes as cancer risk factors: time for a reassessment? Cancer Epidemiol Biomarkers Prev 2001; 10: 1233-1237.
4. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomark Prev 1997; 6: 733-743.
5. Cotton SC, Sharp L, Little J, Brockton N. Glutathione S transferase polymorphisms and colorectal cancer. Am J Epidemiol 2000; 151: 7-32.
6. Webb G, Vaska V, Coogan M, Board P. Chromosomal localization of the gene for the human theta class glutathione transferase (GSTT1). Genomics 1996; 33: 121-123.
7. Coggan M, Whitbread L, Whittington A, Board P. Structure and organization of the human theta-class glutathione S-transferase and D-dopachrome tautomerase gene complex. Biochem J 1998; 334: 617-623.
8. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000; 463: 247-283.
9. Leng S, Dai Y, Niu Y, et al. Effects of genetic polymorphisms of metabolic enzymes on cytokinesis-block micronucleus in peripheral blood lymphocyte among coke-oven workers. Cancer Epidemiol Biomarkers Prev 2004; 13: 1631-1639.
10. Ali-Osman F, Akande O, Antoun G, Mao J-X, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione Stransferase pi gene variants. J Biol Chem 1997; 272: 10004-10012.
11. Lyons TJ. Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes? Diabetes Med 1991; 8: 411-419.
12. Ryberg D, Skaug V, Hewer A, et al. Genotype of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997; 18: 1285-1289.
13. Watters JW, McLeod HL. Recent advances in the pharmacogenetics of cancer chemotherapy. Curr Opin Mol Ther 2002; 4: 565-571.
14. Fujita H, Narita T, Meguro H, et al. No association of glutathione-S-transferase M1 gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic patients. Ren Fail 2000; 22: 479-486.
15. Watanabe I, Tomita A, Shimizu M, et al. A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus. Clin Pharmacol Ther 2003; 73: 435-455.
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 1997, Report Diabetes Care; 20(7).
17. Ko Y, Koch B, Harth V Rapid analysis of GSTM1, GSTT1 and GSTP1 polymorphisms using real-time polymerase chain reaction. Pharmacogenetics 2000; 10: 271-274.
18. Ha H, Kim KH. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int 1995; 48(Suppl. 51):S18-S21.
19. Lehmann R, Schleicher ED. Molecular mechanisms of diabetic nephropathy. Clin Chim Acta 2000; 297: 135-144.
20. Gallou G, Ruelland A, Legras B, Maugendre D, Allanic H, Cloarec L. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 1993; 214: 227-234.
21. Bayness JW, Thorpe SR. Role of oxidative stress in diabetic complications (A new perspective to an old paradigm). Diabetes 1999; 48: 1-9.
22. Hayes JD, Strange RC. Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 1995; 22: 193-207.
23. Strange RC, Fryer AA. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ 1999; 148: 231-249.